You are now leaving our website and heading to a third-party website that we do not operate. We are not responsible for the content of the third-party website. You are advised to review its privacy policy as it may differ from ours.

Are you sure you want to leave?




Access leaflets and other resources about chronic kidney disease–mineral and bone disorder (CKD–MBD) and the challenges of treating secondary hyperparathyroidism (SHPT).

Consent form for HCPs

If you, as a HCP, wish to receive electronic promotional and non-promotional information from the Vifor Pharma Group, please subscribe using this form.

Your details

Workplace details

Communication preferences

Select the channels through which you agree to receive the communications and specify the corresponding contact details.
I hereby consent to receive communications from the Vifor Pharma Group, including promotional and non-promotional information, through the channels I have selected above, as specified in the privacy notice